Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year
Showing DOI matching
10.1158/1078-0432.CCR-15-1136
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes JOURNAL ARTICLE published 15 February 2016 in Clinical Cancer Research Research funded by The Donald A Adam Comprehensive Melanoma Research Center, NCI Cancer Center Support Grant, NCI (RO1CA129594,FDARO1FD-003511,P30 CA076292) |